Behavioral Therapy Development for Methamphetamine Abuse

University of California, Los Angeles3 sites in 1 countrySeptember 2004

ConditionsThe Study Was Designed to Develop a Cognitive Behavioral Approach to Treating Methamphetamine Abuse in HIV Primary Care Settings

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: The Study Was Designed to Develop a Cognitive Behavioral Approach to Treating Methamphetamine Abuse in HIV Primary Care Settings
Sponsor: University of California, Los Angeles
Locations: 3
Primary Endpoint: Medication compliance
Status: Withdrawn
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is...to assess whether placing a substance abuse intervention for HIV+ methamphetamine users within an HIV medical care setting improves rates of follow-up on referral to treatment by primary care physicians; reduces drug use and sexual risk behaviors more than treatment-as-usual; and increases rates of adherence to HIV medication regimens.

Registry

clinicaltrials.gov

Start Date

September 2004

End Date

May 2007

Last Updated

6 years ago

Study Type

Interventional

Sex

Male

Investigators

Sponsor

University of California, Los Angeles

Responsible Party

Principal Investigator

Steve Shoptaw

Professor

University of California, Los Angeles

Eligibility Criteria

Inclusion Criteria

•HIV-seropositive, GBM receiving medical treatment for HIV for at least 30 days prior to signing informed consent at the UCLA CARE clinic, aged 18-65
•Willing to give informed consent and comply with study procedures;
•Willing to provide consent to contact treating physicians and pharmacies to assess adherence to HIV medications;
•Diagnosed with current methamphetamine abuse as determined by MINI; and
•Interested in seeking treatment for their methamphetamine abuse and in participating in this research project.

Exclusion Criteria

•Unwilling to give, or withdrawal of, informed consent;
•Inability to understand nature of study;
•A psychiatric condition that, in the principal investigator's judgment, warrants additional intervention to ensure participant safety (e.g., meets DSM-IV-TR criteria for current bipolar disorder or a psychotic disorder);
•Current suicidal ideation or suicide attempt within the past 3 months; and
•Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI.
•Total lack of any type of healthcare coverage. These potential participants will be given low-fee treatment referrals.